What Are Itraconazole Side Effects for Sporotrichosis?
At a Glance
Common itraconazole side effects include nausea, diarrhea, and headaches. Because it can cause silent liver stress and rarely heart failure, routine liver blood tests are required. Take capsules with a full meal or acidic drink, and avoid statins, antacids, and grapefruit.
In this answer
4 sections
When treating sporotrichosis with itraconazole for several months, you may experience common day-to-day side effects like nausea, diarrhea, or an upset stomach [1]. Because itraconazole can cause stress to your liver, your doctor will require routine blood tests to monitor your liver enzymes and catch any issues early [2][3]. Additionally, standard itraconazole capsules require strong stomach acid to be absorbed properly, meaning they should be taken with a full meal or an acidic drink like cola [4][5].
Common, Everyday Side Effects
Itraconazole is generally well-tolerated, but because you will be taking it for 3 to 6 months to fully clear the sporotrichosis infection, you may experience some minor side effects [6][7]. The most common issues are related to the digestive system [1]. You might notice:
- Nausea or vomiting: Feeling sick to your stomach [1].
- Diarrhea or GI upset: Changes in your bowel habits or abdominal discomfort [1].
- Headaches and dizziness: Some patients report mild head pain or feeling lightheaded [8].
Tips for managing daily side effects: Taking your capsules in the middle of a large meal not only helps with absorption but can also cushion your stomach and reduce nausea [5]. If you find the medication makes you feel slightly dizzy or nauseous, ask your doctor if you can take your dose in the evening so you can sleep through the worst of it.
If these side effects become severe or make it difficult to continue taking the medication, let your doctor know. There are different formulations of itraconazole (like an oral solution instead of capsules) that might be easier to tolerate [5][9].
Important Risks: Heart Failure and Liver Stress
There are two major risks to understand when taking long-term itraconazole:
1. Risk of Heart Failure
While it is rare for a healthy person to suddenly develop heart issues, itraconazole carries a strict medical warning because it can sometimes cause or worsen congestive heart failure [10][11]. If you have a history of heart disease, your doctor might choose a different medication. Even if you don’t have heart problems, you should immediately contact your doctor if you notice any of these signs:
- Shortness of breath
- Sudden or unexplained weight gain
- Swelling in your feet, ankles, or legs [11][12]
2. Liver Stress and the Need for Blood Tests
Itraconazole is known to be one of the antifungal medications with a higher risk of hepatotoxicity (liver damage or stress) [13][3].
Because early liver stress often causes no physical symptoms, your doctor will order routine blood tests to check your liver enzymes [2]. They will likely test your blood after the first 2-4 weeks, and then periodically (often once a month) while you are on the medication. These tests allow your care team to:
- Monitor how well your liver is handling the medication over the 3-6 month treatment [14].
- Detect any early signs of liver stress while it is completely “silent,” long before it causes visible symptoms like yellowing of the skin (jaundice), unusual fatigue, or dark urine [2].
If your liver enzymes begin to rise, you don’t need to panic. Your doctor will see this on your blood test and can adjust your dose or switch you to a different treatment safely [15].
Getting the Most Out of Your Medication: The Role of Stomach Acid
For itraconazole capsules to dissolve and enter your bloodstream effectively, your stomach must be highly acidic [4][16]. If the medication is not absorbed properly, it won’t be able to fight the sporotrichosis fungus [17].
To ensure your body absorbs the medication:
- Take capsules with a full meal: Eating food naturally increases your stomach acid [5].
- Use acidic drinks: Some doctors recommend taking the capsules with an acidic beverage like cola to help it dissolve [4][5].
- Avoid acid-reducing medications: Drugs used for heartburn or reflux, such as proton pump inhibitors (PPIs) and antacids, reduce stomach acid and will severely block the absorption of itraconazole capsules [18][19].
(Note: If you are prescribed the liquid oral solution of itraconazole instead of capsules, the rules are different. The liquid solution does not require an acidic stomach and is usually taken on an empty stomach [4][5]. Always confirm with your pharmacist which version you have.)
Drug and Food Interactions
Itraconazole strongly interferes with an enzyme in your body (CYP3A4) that processes many other common medications [20][21].
Because of this, it is very dangerous to take itraconazole with certain cholesterol-lowering drugs (statins) like simvastatin (Zocor) or lovastatin (Altoprev) [22][23]. Taking them together can cause severe muscle damage.
Additionally, grapefruit and grapefruit juice affect this exact same enzyme [24][25]. Consuming grapefruit while taking itraconazole can alter how the drug is absorbed and processed, potentially increasing your risk of side effects [26]. You should avoid grapefruit for the duration of your treatment.
Always make sure your doctor and pharmacist have an up-to-date list of every medication, supplement, and over-the-counter drug you take.
Common questions in this guide
Why do I need blood tests while taking itraconazole?
Should I take itraconazole with food?
Can I take antacids or heartburn medication while on itraconazole?
What are the warning signs of heart problems from itraconazole?
Can I eat grapefruit while taking itraconazole?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.What is the exact schedule for my liver enzyme blood tests, and where should I get them drawn?
- 2.Do I need to make any changes to my current prescription medications, especially cholesterol or blood pressure drugs, while I'm on itraconazole?
- 3.If the daily nausea or stomach upset becomes difficult to manage, am I a candidate to switch to the liquid oral solution of itraconazole?
- 4.What over-the-counter pain relievers or cold medicines are safe to take if I get a headache while on this antifungal?
- 5.Should I adjust the timing of my dose to the evening if I feel dizzy or nauseous during the day?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
Related questions
References
References (26)
- 1
Tolerability of oral itraconazole and voriconazole for the treatment of chronic pulmonary aspergillosis: A systematic review and meta-analysis.
Olum R, Baluku JB, Kazibwe A, et al.
PloS one 2020; (15(10)):e0240374 doi:10.1371/journal.pone.0240374.
PMID: 33052954 - 2
Hepatic Failure in a Patient Receiving Itraconazole for Pulmonary Histoplasmosis-Case Report and Literature Review.
Pettit NN, Pisano J, Weber S, Ridgway J
American journal of therapeutics 2016; (23(5)):e1215-21 doi:10.1097/MJT.0000000000000313.
PMID: 26291595 - 3
Antifungal Drugs and Drug-Induced Liver Injury: A Real-World Study Leveraging the FDA Adverse Event Reporting System Database.
Zhou ZX, Yin XD, Zhang Y, et al.
Frontiers in pharmacology 2022; (13()):891336 doi:10.3389/fphar.2022.891336.
PMID: 35571077 - 4
Application of tiny-TIM as a mechanistic tool to investigate the in vitro performance of different itraconazole formulations under physiologically relevant conditions.
López Mármol Á, Fischer PL, Wahl A, et al.
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 2022; (173()):106165 doi:10.1016/j.ejps.2022.106165.
PMID: 35278610 - 5
Prediction of Bioequivalence and Food Effect Using Flux- and Solubility-Based Methods.
Borbás E, Kádár S, Tsinman K, et al.
Molecular pharmaceutics 2019; (16(10)):4121-4130 doi:10.1021/acs.molpharmaceut.9b00406.
PMID: 31525051 - 6
Osteoarticular sporotrichosis in an immunocompetent patient.
Sendrasoa FA, Ranaivo IM, Sata M, et al.
Medical mycology case reports 2021; (32()):50-52 doi:10.1016/j.mmcr.2021.03.007.
PMID: 33868910 - 7
Side effects associated with itraconazole therapy.
Osborn MR, Zuniga-Moya JC, Mazi PB, et al.
The Journal of antimicrobial chemotherapy 2025; (80(2)):503-508 doi:10.1093/jac/dkae437.
PMID: 39658087 - 8
MSG-15: Super-Bioavailability Itraconazole Versus Conventional Itraconazole in the Treatment of Endemic Mycoses-A Multicenter, Open-Label, Randomized Comparative Trial.
Spec A, Thompson GR, Miceli MH, et al.
Open forum infectious diseases 2024; (11(3)):ofae010 doi:10.1093/ofid/ofae010.
PMID: 38440302 - 9
When Interactions Between Bile Salts and Cyclodextrin Cause a Negative Food Effect: Dynamic Dissolution/Permeation Studies with Itraconazole (Sporanox®) and Biomimetic Media.
Cuoco A, Eriksen JB, Luppi B, et al.
Journal of pharmaceutical sciences 2023; (112(5)):1372-1378 doi:10.1016/j.xphs.2022.12.010.
PMID: 36539063 - 10
Heart failure induced by itraconazole.
Rodrigo-Troyano A, Mediavilla MM, Garin N, Güell R
Medicina clinica 2017; (148(2)):69-70 doi:10.1016/j.medcli.2016.09.040.
PMID: 27914674 - 11
The Many Faces of Itraconazole Cardiac Toxicity.
Teaford HR, Abu Saleh OM, Villarraga HR, et al.
Mayo Clinic proceedings. Innovations, quality & outcomes 2020; (4(5)):588-594 doi:10.1016/j.mayocpiqo.2020.05.006.
PMID: 33083707 - 12
Cardiac Implications of Itraconazole Therapy in Histoplasmosis Patients.
Sabanci R, Saeed M, Watat K, Wilcox M
Cureus 2024; (16(4)):e59076 doi:10.7759/cureus.59076.
PMID: 38803747 - 13
[Disseminated cutaneous sporotrichosis with joint involvement in a woman with type 2 diabetes].
Solorzano S, Ramirez R, Cabada MM, et al.
Revista peruana de medicina experimental y salud publica 2015; (32(1)):187-90.
PMID: 26102124 - 14
Hepatobiliary disorders associated with triazole antifungal agents: a disproportionality and Bayesian analysis based on the FAERS database.
Nie R, Yu B, Li Q, et al.
Naunyn-Schmiedeberg's archives of pharmacology 2026; (399(3)):4427-4440 doi:10.1007/s00210-025-04746-z.
PMID: 41111132 - 15
Lymphocutaneous Sporotrichosis Refractory to First-Line Treatment.
Belda W, Domingues Passero LF, Stradioto Casolato AT
Case reports in dermatological medicine 2021; (2021()):9453701 doi:10.1155/2021/9453701.
PMID: 34659843 - 16
Novel cocrystals of itraconazole: Insights from phase diagrams, formation thermodynamics and solubility.
Vasilev NA, Surov AO, Voronin AP, et al.
International journal of pharmaceutics 2021; (599()):120441 doi:10.1016/j.ijpharm.2021.120441.
PMID: 33675927 - 17
Efficacy of generic forms of itraconazole capsule in treating subjects with chronic pulmonary aspergillosis.
Sehgal IS, Vinay K, Dhooria S, et al.
Mycoses 2023; (66(7)):576-584 doi:10.1111/myc.13583.
PMID: 36967117 - 18
Prediction of gastric pH-mediated drug exposure using physiologically-based pharmacokinetic modeling: A case study of itraconazole.
Yang E, Yu KS, Lee S
CPT: pharmacometrics & systems pharmacology 2023; (12(6)):865-877 doi:10.1002/psp4.12959.
PMID: 36967484 - 19
Population In Vitro-In Vivo Correlation Model Linking Gastrointestinal Transit Time, pH, and Pharmacokinetics: Itraconazole as a Model Drug.
Abuhelwa AY, Mudge S, Hayes D, et al.
Pharmaceutical research 2016; (33(7)):1782-94 doi:10.1007/s11095-016-1917-1.
PMID: 27119846 - 20
Itraconazole interferes in the pharmacokinetics of fuzuloparib in healthy volunteers.
Hu C, Zhang Y, Pei T, et al.
Cancer chemotherapy and pharmacology 2023; (91(6)):523-529 doi:10.1007/s00280-023-04536-5.
PMID: 37166499 - 21
The effect of itraconazole and rifampicin on the pharmacokinetics of osimertinib.
Vishwanathan K, Dickinson PA, So K, et al.
British journal of clinical pharmacology 2018; (84(6)):1156-1169 doi:10.1111/bcp.13534.
PMID: 29381826 - 22
Clinical Guidance for Managing Statin and Antimicrobial Drug-Drug Interactions.
Hylton Gravatt LA, Flurie RW, Lajthia E, Dixon DL
Current atherosclerosis reports 2017; (19(11)):46 doi:10.1007/s11883-017-0682-x.
PMID: 28990114 - 23
[State of the Art: Statin Therapy].
Laufs U, Weingärtner O, Kassner U, Schatz U
Deutsche medizinische Wochenschrift (1946) 2022; (147(1-02)):62-68 doi:10.1055/a-1516-2471.
PMID: 34872149 - 24
A Phase 1 Pharmacokinetic Drug Interaction Study of Belumosudil Coadministered With CYP3A4 Inhibitors and Inducers and Proton Pump Inhibitors.
Schueller O, Willson A, Singh N, et al.
Clinical pharmacology in drug development 2022; (11(7)):795-806 doi:10.1002/cpdd.1082.
PMID: 35230741 - 25
An open-label study to explore the optimal design of CYP3A drug-drug interaction clinical trials in healthy Chinese people.
Chen J, Li J, Wu J, et al.
Pharmacology research & perspectives 2024; (12(4)):e1252 doi:10.1002/prp2.1252.
PMID: 39073244 - 26
Physiologically Based Pharmacokinetic Modeling of Bergamottin and 6,7-Dihydroxybergamottin to Describe CYP3A4 Mediated Grapefruit-Drug Interactions.
Fuhr LM, Marok FZ, Fuhr U, et al.
Clinical pharmacology and therapeutics 2023; (114(2)):470-482 doi:10.1002/cpt.2968.
PMID: 37307228
This page provides educational information on itraconazole side effects for sporotrichosis. It is not medical advice. Always consult your doctor or pharmacist before making changes to your medication or diet.
Get notified when new evidence is published on Sporotrichosis.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.